Tanshinone IIA has been found to alleviate DKD by inhibiting the PI3K/Akt/mTOR pathway in podocytes, regulating autophagy, and reducing inflammation (Li et al., 2024). The gene discussed is AKT1; the disease is diabetic kidney disease.